248 related articles for article (PubMed ID: 34684874)
1. Lipid A-Mediated Bacterial-Host Chemical Ecology: Synthetic Research of Bacterial Lipid As and Their Development as Adjuvants.
Shimoyama A; Fukase K
Molecules; 2021 Oct; 26(20):. PubMed ID: 34684874
[TBL] [Abstract][Full Text] [Related]
2. Chemical Synthesis and Immunomodulatory Functions of Bacterial Lipid As.
Shimoyama A; Fukase K
Methods Mol Biol; 2023; 2613():33-53. PubMed ID: 36587069
[TBL] [Abstract][Full Text] [Related]
3. The immunobiology of toll-like receptor 4 agonists: from endotoxin tolerance to immunoadjuvants.
Bohannon JK; Hernandez A; Enkhbaatar P; Adams WL; Sherwood ER
Shock; 2013 Dec; 40(6):451-62. PubMed ID: 23989337
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of a dimeric monosaccharide lipid A mimic and its synergistic effect on the immunostimulatory activity of lipopolysaccharide.
Lewicky JD; Ulanova M; Jiang ZH
Carbohydr Res; 2011 Sep; 346(13):1705-13. PubMed ID: 21689810
[TBL] [Abstract][Full Text] [Related]
5. Lipopolysaccharide from Gut-Associated Lymphoid-Tissue-Resident Alcaligenes faecalis: Complete Structure Determination and Chemical Synthesis of Its Lipid A.
Shimoyama A; Di Lorenzo F; Yamaura H; Mizote K; Palmigiano A; Pither MD; Speciale I; Uto T; Masui S; Sturiale L; Garozzo D; Hosomi K; Shibata N; Kabayama K; Fujimoto Y; Silipo A; Kunisawa J; Kiyono H; Molinaro A; Fukase K
Angew Chem Int Ed Engl; 2021 Apr; 60(18):10023-10031. PubMed ID: 33522128
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant activity of naturally occurring monophosphoryl lipopolysaccharide preparations from mucosa-associated bacteria.
Chilton PM; Hadel DM; To TT; Mitchell TC; Darveau RP
Infect Immun; 2013 Sep; 81(9):3317-25. PubMed ID: 23798540
[TBL] [Abstract][Full Text] [Related]
7. Supplementation of whole-cell pertussis vaccines with lipopolysaccharide analogs: modification of vaccine-induced immune responses.
Geurtsen J; Fransen F; Vandebriel RJ; Gremmer ER; de la Fonteyne-Blankestijn LJ; Kuipers B; Tommassen J; van der Ley P
Vaccine; 2008 Feb; 26(7):899-906. PubMed ID: 18207288
[TBL] [Abstract][Full Text] [Related]
8. Putting endotoxin to work for us: monophosphoryl lipid A as a safe and effective vaccine adjuvant.
Casella CR; Mitchell TC
Cell Mol Life Sci; 2008 Oct; 65(20):3231-40. PubMed ID: 18668203
[TBL] [Abstract][Full Text] [Related]
9. Rationally Designed TLR4 Ligands for Vaccine Adjuvant Discovery.
Gregg KA; Harberts E; Gardner FM; Pelletier MR; Cayatte C; Yu L; McCarthy MP; Marshall JD; Ernst RK
mBio; 2017 May; 8(3):. PubMed ID: 28487429
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the structure and immunostimulatory activity of a vaccine adjuvant, de-O-acylated lipooligosaccharide.
Han JE; Wui SR; Kim KS; Cho YJ; Cho WJ; Lee NG
PLoS One; 2014; 9(1):e85838. PubMed ID: 24465739
[TBL] [Abstract][Full Text] [Related]
11. Novel adjuvants derived from attenuated lipopolysaccharides and lipid As of purple non-sulfur photosynthetic bacteria.
Masoud H
Vaccine; 2019 Jun; 37(26):3472-3477. PubMed ID: 31097350
[TBL] [Abstract][Full Text] [Related]
12. Synthetic TLR4-active glycolipids as vaccine adjuvants and stand-alone immunotherapeutics.
Johnson DA
Curr Top Med Chem; 2008; 8(2):64-79. PubMed ID: 18289078
[TBL] [Abstract][Full Text] [Related]
13. Antibodies to lipopolysaccharide.
Poxton IR
J Immunol Methods; 1995 Oct; 186(1):1-15. PubMed ID: 7561138
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationships of bacterial lipopolysaccharides (endotoxins). Current and future aspects.
Brade H; Brade L; Rietschel ET
Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Apr; 268(2):151-79. PubMed ID: 3293332
[No Abstract] [Full Text] [Related]
15. Lipopolysaccharide, lipid A, and liposomes containing lipid A as immunologic adjuvants.
Alving CR
Immunobiology; 1993 Apr; 187(3-5):430-46. PubMed ID: 8330907
[TBL] [Abstract][Full Text] [Related]
16. The chemical structure of bacterial endotoxin in relation to bioactivity.
Rietschel ET; Kirikae T; Schade FU; Ulmer AJ; Holst O; Brade H; Schmidt G; Mamat U; Grimmecke HD; Kusumoto S
Immunobiology; 1993 Apr; 187(3-5):169-90. PubMed ID: 8330896
[TBL] [Abstract][Full Text] [Related]
17. Lipopolysaccharide lipid A: A promising molecule for new immunity-based therapies and antibiotics.
Garcia-Vello P; Di Lorenzo F; Zucchetta D; Zamyatina A; De Castro C; Molinaro A
Pharmacol Ther; 2022 Feb; 230():107970. PubMed ID: 34454000
[TBL] [Abstract][Full Text] [Related]
18. Biological activities of fragments derived from Bordetella pertussis endotoxin: isolation of a nontoxic, Shwartzman-negative lipid A possessing high adjuvant properties.
Ayme G; Caroff M; Chaby R; Haeffner-Cavaillon N; Le Dur A; Moreau M; Muset M; Mynard MC; Roumiantzeff M; Schulz D; Szabó L
Infect Immun; 1980 Mar; 27(3):739-45. PubMed ID: 6247278
[TBL] [Abstract][Full Text] [Related]
19. A case for an endotoxic conformation.
Seydel U; Brandenburg K; Rietschel ET
Prog Clin Biol Res; 1994; 388():17-30. PubMed ID: 7831357
[TBL] [Abstract][Full Text] [Related]
20. Outer Membrane Lipid Secretion and the Innate Immune Response to Gram-Negative Bacteria.
Giordano NP; Cian MB; Dalebroux ZD
Infect Immun; 2020 Jun; 88(7):. PubMed ID: 32253250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
